Related Experiment Video
Updated: Feb 16, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling
Cindy Chiang1, Eva-Katharina Pauli2, Jennifer Biryukov3
1Department of Microbiology, The University of Chicago, Chicago, Illinois, USA.
Abstract:
Retinoic acid-inducible gene I (RIG-I) is a key pattern recognition receptor that senses viral RNA and interacts with the mitochondrial adaptor MAVS, triggering a signaling cascade that results in the production of type I interferons (IFNs). This signaling axis is initiated by K63-linked ubiquitination of RIG-I mediated by the E3 ubiquitin ligase TRIM25, which promotes the interaction of RIG-I with MAVS. USP15 was recently identified as an upstream regulator of TRIM25, stabilizing the enzyme through removal of degradative K48-linked polyubiquitin, ultimately promoting RIG-I-dependent cytokine responses. Here, we show that the E6 oncoprotein of human papillomavirus type 16 (HPV16) as well as of other HPV types form a complex with TRIM25 and USP15 in human cells. In the presence of E6, the K48-linked ubiquitination of TRIM25 was markedly increased, and in line with this, TRIM25 degradation was enhanced. Our results further showed that E6 inhibited the TRIM25-mediated K63-linked ubiquitination of RIG-I and its CARD-dependent interaction with MAVS. HPV16 E6, but not E7, suppressed the RIG-I-mediated induction of IFN-β, chemokines, and IFN-stimulated genes (ISGs). Finally, CRISPR-Cas9 gene targeting in human keratinocytes showed that the TRIM25-RIG-I-MAVS triad is important for eliciting an antiviral immune response to HPV16 infection. Our study thus identifies a novel immune escape mechanism that is conserved among different HPV strains and further indicates that the RIG-I signaling pathway plays an important role in the innate immune response to HPV infection.IMPORTANCE Persistent infection and tumorigenesis by HPVs are known to require viral manipulation of a variety of cellular processes, including those involved in innate immune responses. Here, we show that the HPV E6 oncoprotein antagonizes the activation of the cytoplasmic innate immune sensor RIG-I by targeting its upstream regulatory enzymes TRIM25 and USP15. We further show that the RIG-I signaling cascade is important for an antiviral innate immune response to HPV16 infection, providing evidence that RIG-I, whose role in sensing RNA virus infections has been well characterized, also plays a crucial role in the antiviral host response to small DNA viruses of the Papillomaviridae family.
Insights
Human papillomavirus type 16 (HPV16) E6 oncoprotein disrupts the RIG-I innate immune pathway by targeting TRIM25 and USP15. This mechanism allows HPV to evade antiviral responses, highlighting RIG-I
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Retinoic acid-inducible gene I (RIG-I) is a crucial pattern recognition receptor sensing viral RNA and initiating type I interferon production via the MAVS adaptor.
- TRIM25-mediated K63-linked ubiquitination of RIG-I is essential for its interaction with MAVS and subsequent immune signaling.
- USP15 deubiquitinates TRIM25, stabilizing it and promoting RIG-I-dependent cytokine responses.
Purpose of the Study:
- To investigate the interaction between HPV16 E6 oncoprotein and the RIG-I signaling pathway components TRIM25 and USP15.
- To elucidate the mechanism by which HPV16 E6 interferes with RIG-I activation and subsequent antiviral responses.
- To determine the role of the TRIM25-RIG-I-MAVS axis in antiviral immunity against HPV16.
Main Methods:
- Co-immunoprecipitation assays to detect complex formation between HPV16 E6, TRIM25, and USP15.
- Western blotting to assess ubiquitination and degradation levels of TRIM25.
- CRISPR-Cas9 gene editing in human keratinocytes to evaluate the antiviral response to HPV16 infection.
Main Results:
- HPV16 E6 forms a complex with TRIM25 and USP15, increasing K48-linked ubiquitination and degradation of TRIM25.
- E6 inhibits TRIM25-mediated K63-linked ubiquitination of RIG-I and its interaction with MAVS, suppressing IFN-β, chemokine, and ISG induction.
- The TRIM25-RIG-I-MAVS pathway is critical for antiviral immunity against HPV16 infection.
Conclusions:
- HPV16 E6 employs a conserved immune escape strategy by targeting TRIM25 and USP15 to antagonize RIG-I activation.
- The RIG-I signaling pathway is vital for innate antiviral immunity against HPV16, a DNA virus.
- This study reveals a novel mechanism of viral immune evasion and underscores RIG-I's role beyond RNA virus sensing.
Related Concept Videos
Regulation of the Unfolded Protein Response
The Unfolded Protein Response
Abnormal Proliferation
Negative Regulator Molecules
The JAK-STAT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

